Epidemiology of fracture risk in the Women’s Health Initiative

Burge R, Dawson-Highes B, Solomon DH, et al.: Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 2006, 21:465–475.

Magaziner J, Hawkes W, Hebel JR, et al.: Recovery from hip fracture in eight areas of function. J Gerontol A Biol Sci Med Sci 2000, 55:M498–M507.

VanStaa TP, Dennison EM, Leufkens HE, Cooper C: Epidemiology of fractures in England and Wales. Bone 2001, 29:517–522.

Sambrook P, Cooper C: Osteoporosis. Lancet 2006, 367:2010–2018.

Marks R, Allegrante JP, Mackenzie CR, Lane JM: Hip fractures among the elderly: causes, consequences and control. Aging Res Rev 2003, 2:57–93.

Heaney RP: Remodeling and skeletal fragility. Osteoporos Int 2003, 14(Suppl):S12–S15.

Johnell O, Kanis JA, Oden A, et al.: Predictive value of bone mineral density for hip and other fractures. J Bone Miner Res 2005, 20:1185–1194.

Wainwright SA, Phipps KR, Stone JV, et al.: A large proportion of fractures in postmenopausal women occur with baseline bone mineral density T-score >= 2.5 [abstract]. J Bone Miner Res 2001, 16:S155.

Henry MJ, Pasco JA, Seeman E, et al.: Assessment of fracture risk: value of random population-based samples: the Geelong Osteoporosis Study. J Clin Densitom 2001, 4:283–289.

Kanis JA, Johnell O, Oden A, et al.: Risk of hip fracture according to World Health Organization criteria for osteopenia and osteoporosis. Bone 2000, 27:585–590.

Hui SL, Slemenda CW, Johnston CC: Age and bone mass as predictors of fracture in a prospective study. J Clin Invest 1988, 81:1804–1809.

Women’s Health Initiative Study Group: Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 1998, 339:733–738.

LaFleur J, McAdam-Marx C, Kirkness C, Brixner DI: Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature. Ann Pharmacother 2008, 42:375–386.

Robbins J, Aragaki AK, Kooperberg C, et al.: Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 2007, 298:2389–2398.

Black DM, Steinbuch M, Palermo L, et al.: An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int 2001, 12:519–528.

Dargent-Molina P, Douchin MN, Cormier C, et al.: Use of clinical risk factors in elderly women with low bone mineral density to identify women at high risk for hip fracture: the EPIDOS prospective study. Osteoporos Int 2002, 13:593–599.

Miller PD, Barles S, Brenneman SK, et al.: An approach for identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med 2004, 164:1113–1120.

McGrother CW, Donaldson MM, Clayton D, et al.: Evaluation of a hip fracture risk score for assessing elderly women: the Melton Osteoporotic Fracture (MOF) study. Osteoporos Int 2002, 13:89–96.

Kanis JA, Oden A, Johnell O, et al.: The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007, 18:133–1046.

Kanis JA, Johnell O, Johansson H, McCloskey E: FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008, 19:385–397.

Kanis JA, on behalf of the World Health Organization Scientific Group: Assessment of Osteoporosis at the Primary Health Care Level. Technical Report 2008. University of Sheffield, UK: WHO Collaborating Center; 2008.

Siris E, Delmas PD: Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application. Osteoporos Int 2008, 19:383–384.

Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al.: Effect of vitamin D on falls: a meta-analysis. JAMA 2004, 291:1999–2006

Lips P: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001, 22:477–501.

Cranney A, Horsley T, O’Donnell S, et al.: Effectiveness and safety of vitamin D in relation to bone health. Rockville, MD: Agency for Healthcare Research and Quality; 2007. Available at http://www.ahrq.gov/clinic/tp/vitadtp.htm . Accessed September 9, 2008.

Cauley JA, LaCroix AZ, Wu LL, et al.: Serum vitamin D concentrations and risk for hip fractures. Ann Intern Med 2008, 149:242–250.

Lee JS, LaCroix AZ, Wu LL, et al.: Associations of serum sex hormone-binding globulin and sex hormone concentrations with hip fracture risk in postmenopausal women. J Clin Endocrin Metab 2008, 93:1796–1803.

Lacroix AZ, Lee JS, Wu L, et al.: Cystatin-C, renal function, and incidence of hip fracture in postmenopausal women. J Am Geriatr Soc 2008 Jul 24 (Epub ahead of print).

Cauley JA, Wampler NS, Barnhart JM, et al.: Incidence of fractures compared to cardiovascular disease and breast cancer: the Women’s Health Initiative Observational Study. Osteoporos Int 2008, Jul 16 (Epub ahead of print).

Cauley JA, Wu L, Wampler N, et al.: Clinical risk factors for fractures in multi-ethnic women: the Women’s Health Initiative. J Bone Miner Res 2007, 22:1816–1826.